Equities research analysts predict that Stryker Co. (NYSE:SYK) will report sales of $2.71 billion for the current quarter, according to Zacks Investment Research. Eleven analysts have provided estimates for Stryker’s earnings. The lowest sales estimate is $2.43 billion and the highest is $3.90 billion. Stryker posted sales of $3.65 billion during the same quarter last […] View Stryker Corporation SYK investment & stock information. Get the latest Stryker Corporation SYK detailed stock quotes, stock data, Real-Time ECN, charts, Recent price changes and earnings estimate revisions indicate this stock lacks momentum and would be a lackluster choice for momentum investors. Style 2 days ago Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid Growth Estimates, SYK, IND, S&P. Current Qtr (06/2020), -68.69, 26.42, - 4.74. SYK: Stryker Corporation broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. 2 days ago Stryker (SYK) continues to benefit from strength in its robotic-arm You can see the complete list of today's Zacks #1 Rank stocks here.
Feb 06, 2020
SYK: Stryker Corporation equity research. Get the latest equity research information from Zacks Investment Research. STRYKER Income Statement, Balance Sheet and Statement of Cash Flows. STRYKER Key Stats, charts, historical data, comparisons and more at Zacks Advisor Tools. Stryker’s shares have underperformed the Zacks Medical Products industry over the past six months (-26.8% vs. -13). The Zacks analyst believes that Stryker continues to gain from its core The Zacks Analyst Blog Highlights: SYK, SHOP, ATVI, TRP and DG. Top Stock Reports for Stryker, Shopify and Activision Blizzard Zacks Investment Research.
The Zacks Analyst Blog Highlights: SYK, SHOP, ATVI, TRP ...
SYK | Stryker Corp | Dividend History | Dividend Channel Tue, Apr 7, 6:19 AM, Zacks Here's Why You Should Hold on to Stryker (SYK) Stock Now Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.
Tue, Apr 7, 6:19 AM, Zacks Here's Why You Should Hold on to Stryker (SYK) Stock Now Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.
Stryker Corporation SYK is scheduled to release fourth-quarter 2019 results on Jan 28 after the closing bell. In the last reported quarter, the company met estimates. Further, it has an average SYK: Stryker Corporation equity research. Get the latest equity research information from Zacks Investment Research. STRYKER Income Statement, Balance Sheet and Statement of Cash Flows. STRYKER Key Stats, charts, historical data, comparisons and more at Zacks Advisor Tools. Stryker’s shares have underperformed the Zacks Medical Products industry over the past six months (-26.8% vs. -13). The Zacks analyst believes that Stryker continues to gain from its core
View detailed financial information, real-time news, videos, quotes and analysis on Stryker Corp. (NYSE:SYK). Explore commentary on Stryker Corp. and hear what the experts at TheStreet are saying
Exploring Stryker (NYSE:SYK) stock? View SYK's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at SYK, Stryker Corp - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders Zacks Equity Research 05/30/2020 05:31 AM ET 30 Apr 2020 (SYK) on Thursday reported first-quarter net income of $493 million. Access a Zacks stock report on SYK at https://www.zacks.com/ap/SYK